Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aveo Pharmaceuticals (AVEO)

Aveo Pharmaceuticals (AVEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 114,562
  • Shares Outstanding, K 160,744
  • Annual Sales, $ 5,410 K
  • Annual Income, $ -5,330 K
  • 60-Month Beta 0.71
  • Price/Sales 22.43
  • Price/Cash Flow N/A
  • Price/Book 6.47
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/08/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.06
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.09
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.49 +48.45%
on 11/11/19
0.82 -12.20%
on 12/02/19
+0.21 (+41.18%)
since 11/08/19
3-Month
0.47 +53.45%
on 11/06/19
1.12 -35.71%
on 09/17/19
-0.20 (-22.12%)
since 09/10/19
52-Week
0.47 +53.45%
on 11/06/19
2.14 -66.36%
on 01/09/19
-1.31 (-64.53%)
since 12/10/18

Most Recent Stories

More News
AVEO Oncology Announces Lancet Oncology Publication of Data from Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma

AVEO Oncology (NASDAQ: AVEO) today announced that previously reported data from its Phase 3 TIVO-3 study were published in The Lancet Oncology. TIVO-3 is the Company's Phase 3 randomized, controlled, multi-center,...

AVEO : 0.72 (+1.02%)
AVEO Oncology to Present at the 31st Annual Piper Jaffray Healthcare Conference

AVEO Oncology (NASDAQ:AVEO) today announced that Michael Bailey, president and chief executive officer, will present at the 31st Annual Piper Jaffray Healthcare Conference in New York on Tuesday, December...

AVEO : 0.72 (+1.02%)
AVEO Oncology Announces Appointment of Scarlett Spring to its Board of Directors

AVEO Oncology (NASDAQ: AVEO) today announced the appointment of Scarlett Spring to its Board of Directors. Ms. Spring brings to AVEO extensive sales, commercial, and leadership experience in the biopharmaceutical...

AVEO : 0.72 (+1.02%)
AVEO Announces Presentation of Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma

--- Outcomes Favor Tivozanib in Patients Previously Treated With Checkpoint Inhibitors as Well as Two VEGFR-TKIs -

AVEO : 0.72 (+1.02%)
Sarepta (SRPT) Stock Down Despite New $48M Gene Therapy Deal

Sarepta (SRPT) expands its footing in the gene therapy field and signs a deal with StrideBio to develop up to eight new treatments.

AVEO : 0.72 (+1.02%)
SRPT : 106.17 (+0.40%)
ALKS : 21.57 (-0.78%)
ANIK : 55.42 (-0.22%)
AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark

AVEO Pharmaceuticals (AVEO) rides high on both earnings and revenue beat in the third quarter. Shares rise.

BMY : 62.09 (+1.32%)
AZN : 47.98 (+0.44%)
BAYRY : 19.1300 (+0.55%)
AVEO : 0.72 (+1.02%)
AVEO: 3Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ AVEO Pharmaceuticals Inc. (AVEO) on Tuesday reported third-quarter net income of $16.4 million, after reporting a loss in the same period a year earlier.

AVEO : 0.72 (+1.02%)
AVEO Reports Third Quarter 2019 Financial Results and Provides Business Update

AVEO Oncology (NASDAQ: AVEO) today reported financial results for the third quarter ended September 30, 2019 and provided a business update.

AVEO : 0.72 (+1.02%)
Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis

Spectrum Pharma (SPPI) posts a narrower-than-expected loss for the third quarter of 2019.

ALKS : 21.57 (-0.78%)
AVEO : 0.72 (+1.02%)
ANIK : 55.42 (-0.22%)
SPPI : 10.35 (+0.58%)
Global Blood's (GBT) Q3 Loss Widens, Voxelotor in Focus

Global Blood (GBT) incurs a wider-than-expected loss in the third quarter of 2019. Moreover, voxelotor for the treatment of sickle cell disease is under review in the United States.

RHHBY : 38.4000 (+0.01%)
GBT : 75.95 (+1.12%)
ALKS : 21.57 (-0.78%)
AVEO : 0.72 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AVEO with:

Business Summary

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is...

See More

Key Turning Points

2nd Resistance Point 0.75
1st Resistance Point 0.74
Last Price 0.72
1st Support Level 0.70
2nd Support Level 0.68

See More

52-Week High 2.14
Fibonacci 61.8% 1.50
Fibonacci 50% 1.30
Fibonacci 38.2% 1.11
Last Price 0.72
52-Week Low 0.47

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar